[go: up one dir, main page]

MX2010003651A - Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal. - Google Patents

Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal.

Info

Publication number
MX2010003651A
MX2010003651A MX2010003651A MX2010003651A MX2010003651A MX 2010003651 A MX2010003651 A MX 2010003651A MX 2010003651 A MX2010003651 A MX 2010003651A MX 2010003651 A MX2010003651 A MX 2010003651A MX 2010003651 A MX2010003651 A MX 2010003651A
Authority
MX
Mexico
Prior art keywords
intestinal
maturation
treatment
gastro
promotion
Prior art date
Application number
MX2010003651A
Other languages
English (en)
Inventor
Fabiana Bar
Gai Ben Dror
Tzafra Cohen
Yael Lifshitz
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40445529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010003651(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of MX2010003651A publication Critical patent/MX2010003651A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14—Organic oxygen compounds
    • A21D2/16—Fatty acid esters
    • A21D2/165—Triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención proporciona un uso de una composición de lípido para la preparación de una composición nutricional, farmacéutica o nutracéutica o un alimento funcional, para la prevención y tratamiento de enfermedades y desórdenes gastrointestinales, y para la promoción del desarrollo, maduración, adaptación y diferenciación intestinal.
MX2010003651A 2007-10-09 2008-10-02 Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal. MX2010003651A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96066407P 2007-10-09 2007-10-09
PCT/IL2008/001311 WO2009047754A2 (en) 2007-10-09 2008-10-02 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation

Publications (1)

Publication Number Publication Date
MX2010003651A true MX2010003651A (es) 2010-07-05

Family

ID=40445529

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003651A MX2010003651A (es) 2007-10-09 2008-10-02 Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal.

Country Status (12)

Country Link
US (3) US9107439B2 (es)
EP (1) EP2207429B2 (es)
KR (1) KR101354547B1 (es)
CN (1) CN101896073B (es)
AU (1) AU2008309140B9 (es)
BR (1) BRPI0818079B8 (es)
CA (1) CA2701161C (es)
DK (1) DK2207429T4 (es)
ES (1) ES2426591T5 (es)
MX (1) MX2010003651A (es)
RU (1) RU2469545C2 (es)
WO (1) WO2009047754A2 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2488283C2 (ru) * 2007-11-01 2013-07-27 Энзимотек Лтд. Липидная смесь для детского питания
US9491955B2 (en) 2008-08-25 2016-11-15 Brandeis University Balanced myristate- and laurate-containing edible oil
WO2011071367A1 (en) * 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
SG184349A1 (en) * 2010-04-26 2012-11-29 Enzymotec Ltd Methods and lipid compositions for promoting development of gut flora
WO2012092087A1 (en) 2010-12-29 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
DK2895007T3 (en) * 2012-09-13 2016-10-03 Specialites Pet Food USE OF FATTY FORMATIONS TO MAINTAIN IMPROVED palatability OF PETS FEED OVER TIME
ES2616079T5 (es) 2013-02-12 2023-03-09 Bunge Loders Croklaan B V Composición de grasa
EP4520179A3 (en) * 2013-03-13 2025-04-16 Prolacta Bioscience, Inc. High fat human milk products
AU2014253403B2 (en) * 2013-04-10 2018-03-01 Nestec S.A. Infant formula with a low content of medium-chain fatty acids in specific proportions, and its use in promoting and/or ensuring a balanced growth in infants
RU2654739C2 (ru) * 2013-04-10 2018-05-22 Нестек С.А. Детская смесь с низким содержанием mcfa в определенных пропорциях и относительно высоким содержанием жирных кислот и ее применение в стимуляции здорового становления когнитивной функции у грудных детей
CN104623637A (zh) 2013-11-07 2015-05-20 健能隆医药技术（上海）有限公司 Il-22二聚体在制备静脉注射药物中的应用
US20180139998A1 (en) * 2015-05-04 2018-05-24 Enzymotec Ltd. Lipid compositions for improving sleep
CN108882745B (zh) * 2016-03-10 2023-08-18 花臣有限公司 脂质组合物及其用途
CN109328069B (zh) 2016-04-15 2023-09-01 亿一生物医药开发(上海)有限公司 Il-22在治疗坏死性小肠结肠炎中的用途
CN107518382A (zh) * 2016-06-21 2017-12-29 丰益(上海)生物技术研发中心有限公司 一种提升肠道的中短链酸丰度的方法
EP3968787A1 (en) 2019-05-15 2022-03-23 N.V. Nutricia Fermented formula for improving intestinal development
CN111011864A (zh) * 2019-12-27 2020-04-17 内蒙古蒙牛乳业（集团）股份有限公司 一种促进肠道健康的营养组分
EP4106794A4 (en) 2020-02-19 2024-03-20 Evive Biotechnology (Shanghai) Ltd METHOD FOR TREATING TRANSPLANT AND HOST DISEASE
AU2021263069A1 (en) * 2020-04-27 2022-11-10 Société des Produits Nestlé S.A. Method for producing milk like products
CN111700178A (zh) * 2020-06-16 2020-09-25 江南大学 一种罗非鱼油或其分提物的应用
CN115104651A (zh) * 2022-05-05 2022-09-27 上海交通大学 有效改善代谢的油脂组合物及其应用
CN116473132B (zh) * 2023-03-30 2024-02-13 江南大学 一种富含山柚油的组合物、制备方法及应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2178752B (en) * 1985-07-12 1989-10-11 Unilever Plc Substitute milk fat
US4753963A (en) 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
ATE155684T1 (de) † 1992-04-28 1997-08-15 Fresenius Ag Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
ES2105712T3 (es) * 1993-05-13 1997-10-16 Loders Croklaan Bv Sustitutivos de grasa de leche humana a partir de mezclas interesterificadas de trigliceridos.
JP2001516343A (ja) * 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
ATE230935T1 (de) * 1997-07-22 2003-02-15 Nestle Sa Lipidzusammensetzung für säuglingsnährpräparat und herstellungsverfahren
JP4175698B2 (ja) * 1998-06-19 2008-11-05 サントリー株式会社 新規なトリグリセリド及びそれを含む組成物
EP1034704A1 (en) 1999-03-12 2000-09-13 Societe Des Produits Nestle S.A. Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
IL158555A0 (en) † 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
WO2006114791A1 (en) * 2005-04-27 2006-11-02 Enzymotec Ltd. Human milk fat substitutes
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007058523A1 (en) † 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
RU2432090C2 (ru) 2006-01-31 2011-10-27 Нестек С.А. Питательная композиция
CN101801200B (zh) 2007-09-17 2014-10-29 康奈尔大学 用于预防或治疗胃肠病症的支链脂肪酸
EP2143340A1 (en) 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids

Also Published As

Publication number Publication date
DK2207429T3 (da) 2013-09-08
EP2207429A2 (en) 2010-07-21
BRPI0818079B1 (pt) 2019-11-05
AU2008309140B2 (en) 2013-05-09
US20100273881A1 (en) 2010-10-28
CA2701161C (en) 2014-01-14
ES2426591T5 (es) 2017-08-16
KR101354547B1 (ko) 2014-01-22
CA2701161A1 (en) 2009-04-16
EP2207429B1 (en) 2013-06-05
BRPI0818079A8 (pt) 2017-10-03
US9107439B2 (en) 2015-08-18
US9561207B2 (en) 2017-02-07
WO2009047754A3 (en) 2009-05-22
CN101896073A (zh) 2010-11-24
DK2207429T4 (en) 2017-04-10
US20160030377A1 (en) 2016-02-04
RU2010117211A (ru) 2011-11-20
BRPI0818079A2 (pt) 2017-06-13
WO2009047754A2 (en) 2009-04-16
AU2008309140A1 (en) 2009-04-16
US8980949B2 (en) 2015-03-17
RU2469545C2 (ru) 2012-12-20
US20140187632A1 (en) 2014-07-03
EP2207429B2 (en) 2016-12-28
ES2426591T3 (es) 2013-10-24
AU2008309140B9 (en) 2013-07-04
CN101896073B (zh) 2013-11-20
BRPI0818079B8 (pt) 2021-07-27
KR20100106951A (ko) 2010-10-04

Similar Documents

Publication Publication Date Title
MX2010003651A (es) Composiciones de lipido para el tratamiento de desordenes gastrointestinales y la promocion del desarrollo y maduracion intestinal.
IL204886B (en) A pharmaceutical preparation for the treatment of disorders of the stomach and intestines independent of food consumption
PT2131680E (pt) Probióticos para melhorar a microflora intestinal
PH12013502192A1 (en) Antibodies against human angiopoietin 2
MX2009012255A (es) Probioticos en ambiente pre y/o postquirurgico.
WO2008128115A3 (en) Low-dose doxepin formulations
WO2007128802A3 (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
WO2007104789A3 (en) Amylin derivatives
MA33075B1 (fr) Composition destinee a la regulation du metabolism des lipides
FI20065593A7 (fi) Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö
MX2009006342A (es) Composicion de complemento alimenticio para tratamiento de enfermedades oculares.
WO2011128627A8 (en) Oral veterinary pharmaceutical and nutraceutical compositions
WO2009071690A3 (de) 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
MY161578A (en) Composition for reducing absorption of dietary fat
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
WO2007109071A3 (en) Hydroxylated polymethoxyflavone compositions
WO2011022393A3 (en) Phosphatidylcholine transfer protein inhibitors
WO2010090611A3 (en) Taste and odor masked pharmaceutical compositions with high bioavailability
WO2008094054A3 (en) 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
PT1972345E (pt) Produto alimentar para nutrição entérica ou oral
IL192782A0 (en) Calcium-enriched food product
UA94434C2 (ru) Экстракт коры дерева рода corynanthe и его применение, лекарственное средство, пищевой продукт с лекарственными или профилактическими свойствами и фармацевтический препарат, который его содержит
WO2008155403A3 (en) Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases
WO2009144278A3 (en) Conglutin-gamma as medicament and diet supplement

Legal Events

Date Code Title Description
FG Grant or registration